Search results
Results from the WOW.Com Content Network
The drug — the brand name for the GLP-1 agonist semaglutide — “significantly reduced weekly alcohol craving,” according to a study published Wednesday, Feb. 12, in the Journal of the ...
GLP-1 receptor agonists are already being used to treat alcohol use disorder in some circumstances, Dr. Sarhan says, noting that this is a growing trend in addiction disorder medicine.
“The reduction in alcohol craving and heavy/binge drinking days is particularly important as cravings are a significant factor for relapse. Having an alternative treatment option could increase ...
Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder. [8]
Alcohol withdrawal symptoms include irritability, fatigue, shaking, sweating, and nausea. Withdrawal from nicotine can cause irritability, fatigue, insomnia, headache, and difficulty concentrating. Many prescription and legal nonprescription substances can also cause withdrawal symptoms when individuals stop consuming them, even if they were ...
Dipsomania is a historical term describing a medical condition involving an uncontrollable craving for alcohol or other drugs. [1] In the 19th century, the term dipsomania was used to refer to a variety of alcohol-related problems, most of which are known today as alcohol use disorder. Dipsomania is occasionally still used to describe a ...
The granddad finally got sober at 50 by getting monthly shots of a drug that manages his cravings. This as-told-to essay is based on a conversation with Jeff Horton, 50, a development operations ...
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses ...